20/20 Biolabs Inc.
AIDX
NASDAQ·Healthcare·Medical - Care Facilities·Mkt cap $7.2M
$0.59
▼ -3.27%
P/E
—
Mkt Cap
$7.2M
52-Wk Range
$0.40–$50.00
52-Week Range
$0.40 - $50.00
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 97.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary cancer screening algorithm technology with clinical validation
- Integrated laboratory infrastructure (CLIAx) supporting diagnostic innovation ecosystem
- Early-mover advantage in multi-cancer early detection blood testing
- SaaS business model enabling scalable recurring revenue from healthcare partnerships
Bear Case
1 risk
- Above-average volatility (beta 1.5).
Growth
Strong growth ahead
Rising demand for non-invasive early cancer detection and preventive screening
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Falling
-29.8% over 3m
Quality
Stable
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying AIDX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Sep 2, 2026
AUG 14, 2026
Reported EPS of -$0.26 vs -$0.12 consensus (-116.7% surprise). Revenue of $730.6K vs $636.0K expected (+14.9%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-116.7%
Revenue trend · last 7Q
—
—
—
—
+16%
+5%
+102%
Q1 23
Q2 23
Q3 24
Q4 24
Q3 25
Q1 26
Q2 26
$419.4K
$335.9K
$361.0K
$536.1K
$418.0K
$353.4K
$730.6K
Margins · last 7Q
Gross
41.7%
Operating
-170.3%
Profit
-376.8%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How AIDX stacks vs Medical - Care Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related